ES2108261T3 - Derivados 2-aminoazucar de macrolidos. - Google Patents

Derivados 2-aminoazucar de macrolidos.

Info

Publication number
ES2108261T3
ES2108261T3 ES93903554T ES93903554T ES2108261T3 ES 2108261 T3 ES2108261 T3 ES 2108261T3 ES 93903554 T ES93903554 T ES 93903554T ES 93903554 T ES93903554 T ES 93903554T ES 2108261 T3 ES2108261 T3 ES 2108261T3
Authority
ES
Spain
Prior art keywords
macrolides
azucar
derivatives
amino
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903554T
Other languages
English (en)
Inventor
Kevin Koch
Gary R Schulte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2108261T3 publication Critical patent/ES2108261T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

LOS MACROLIDOS DE LA FORMULA (I) Y LOS METODOS DE TRATAMIENTO DE RESISTENCIA A LOS TRANSPLANTES, INFECCIONES DE HONGOS Y ENFERMEDADES AUTOINMUNES TALES COMO ARTRITIS REUMATOIDE Y PSORIASIS QUE USAN DICHOS MACROLIDOS DE LA FORMULA (I), EN DONDE N ES 1 O 2; A Y B VAN JUNTOS Y FORMAN =O O A Y B VAN SEPARADAMENTE Y SON CADA UNO H O A ES OH Y B ES H; R1 ES UN GRUPO 2-AMINOGLICOSIL; R2 ES OH O UN GRUPO GLICOSILOXI; Y R3 ES UN GRUPO ALQUILO O ALILO.
ES93903554T 1992-03-02 1993-01-27 Derivados 2-aminoazucar de macrolidos. Expired - Lifetime ES2108261T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84433992A 1992-03-02 1992-03-02

Publications (1)

Publication Number Publication Date
ES2108261T3 true ES2108261T3 (es) 1997-12-16

Family

ID=25292446

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903554T Expired - Lifetime ES2108261T3 (es) 1992-03-02 1993-01-27 Derivados 2-aminoazucar de macrolidos.

Country Status (11)

Country Link
US (1) US5631235A (es)
EP (1) EP0636136B1 (es)
JP (1) JP2562001B2 (es)
AT (1) ATE159725T1 (es)
CA (1) CA2131373C (es)
DE (1) DE69314947T2 (es)
DK (1) DK0636136T3 (es)
ES (1) ES2108261T3 (es)
FI (1) FI107537B (es)
GR (1) GR3025672T3 (es)
WO (1) WO1993018048A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
US7160867B2 (en) 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
WO1991002736A1 (en) * 1989-08-18 1991-03-07 Fisons Plc Macrocyclic compounds
DK0427680T3 (da) * 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
FI107537B (fi) 2001-08-31
EP0636136B1 (en) 1997-10-29
DK0636136T3 (da) 1997-12-22
CA2131373A1 (en) 1993-09-16
ATE159725T1 (de) 1997-11-15
US5631235A (en) 1997-05-20
JP2562001B2 (ja) 1996-12-11
CA2131373C (en) 1999-01-26
JPH07500350A (ja) 1995-01-12
EP0636136A1 (en) 1995-02-01
DE69314947D1 (de) 1997-12-04
FI944015A0 (fi) 1994-09-01
WO1993018048A1 (en) 1993-09-16
FI944015L (fi) 1994-09-01
GR3025672T3 (en) 1998-03-31
DE69314947T2 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
ES2160593T3 (es) Desosamino-derivados de microlidos como inmunosupresores y agentes antifungicos.
NO20000762D0 (no) Anvendelse av substituerte adeninderivater til behandling av multippel sklerose
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
DE69109125D1 (de) Ringverknüpfte analoge von stickstoffenthaltenden nichtaromatischen heterocyclen.
SV1996000033A (es) Isotiazolonas
ES2108261T3 (es) Derivados 2-aminoazucar de macrolidos.
AR247391A1 (es) Procedimiento para la preparacion de sulfatos ciclicos
SE7607615L (sv) Antiinflammatoriska medel
PH22243A (en) Trisubstituted pyrimido(5,4-d)pyrimidines and salts thereof
ATE27817T1 (de) Phenylpiperazin-derivate und verfahren zu deren herstellung.
PE20000734A1 (es) Compuestos heterociclicos derivados de furopiridina y su uso terapeutico
DK583184A (da) Substituerede o-acyl-glycosylamider, fremgangsmaader til deres fremstilling samt deres anvendelse
ATE170522T1 (de) Aminoalkylcarbamatester von eserolin verwendbar als inhibitoren von cholinesteraseaktivität und verfahren zu deren herstellung
ES2102642T3 (es) Derivados azucares de macrolidos.
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
ES2138366T3 (es) Indol carbamatos como antagonistas de leucotrienos.
BE598472A (fr) Procédé d'obtention biologique de la streptokinase
ES2159693T3 (es) Ligandos 5ht1dalfa y 5ht2a.
ES2058580T3 (es) Nuevos beta-d-feniltioxilosidos, su metodo de preparacion y su uso como medicamentos.
PT82071B (pt) Processo para a preparacao de derivados de homocisteina tiolactona
OA09487A (fr) "Procédé de préparation de nouvelles pyrrolo (1,2-a)thiéno (3,2-f) diazépines(1,4)".
SE8504538D0 (sv) Carbapenem antibiotics
ES2089669T3 (es) Utilizacion de los derivados de isoquinolinona en el tratamiento de la hiperlipoproteinemia.
DK360981A (da) Fremgangsmaade til fremstilling af 4-lavere alkyl-3-phenoxypyridin-1-oxider
ES379869A1 (es) Procedimiento para la obtencion de derivados basicamente sustituidos de la 1,2,3-benzotriazin-4 (3h)-ona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 636136

Country of ref document: ES